Font Size: a A A
Keyword [Adenocarcinoma of the esophagogastric junction]
Result: 41 - 59 | Page: 3 of 3
41. Comparison Of Short-term And Long-term Outcomes Following Minimally Invasive Vs. Open Sweet Esophagectomy For Adenocarcinoma Of The Esophagogastric Junction
42. Effect Of Surgical Approach On Survival Prognosis Of Siewert Type Ⅰ/Ⅱ Adenocarcinoma Of The Esophagogastric Junction
43. The Feasibility And Efficacy Of Totally Laparoscopic Total Gastrectomy For Treating Siewert Type Ⅱ/Ⅲ Adenocarcinoma Of The Esophagogastric Junction
44. Comparative Study On The Clinical Efficacy Of Different Digestive Tract Reconstruction Methods After Proximal Gastrectomy For Adenocarcinoma Of The Esophagogastric Junction
45. Comparative Study On The Short-term Efficacy Of Laparoscopic Total Gastrectomy With Semi-end-to-end Esophagojejunal Anastomosis And Overlap Anastomosis For Adenocarcinoma Of The Esophagogastric Junction
46. Development And Validation Of Nomogram And Risk Classification System Predicting Overall Survival In Patients With Stage Ⅳ Siewert Type Ⅱ Adenocarcinoma Of The Esophagogastric Junction
47. Comparative Analysis Of Laparoscopic Proximal Gastrectomy Plus Semiembedded Valve Anastomosis With Laparoscopic Total Gastrectomy For Adenocarcinoma Of The Esophagogastric Junction
48. Effect Of The Whole Course Individualized Enteral Nutrition Support Treatment On Neoadjuvant Chemoradiotherapy In Siewert Ⅱ And Ⅲ Local Advanced Adenocarcinoma Of The Esophagogastric Junction
49. Role And Mechanism Of SMC4 In Adenocarcinoma Of The Esophagogastric Junction
50. Comparison Of The Effect Of Different Surgical Approaches On The Treatment Of Siewert Type Ⅱ Esophagogastric Junction Adenocarcinoma By Proximal Gastrectomy
51. Perioperative Period And Long-term Survival Of Adenocarcinoma Of Esophagogastric Junction Treated By Different Surgical Approaches Clinical Study
52. Construction,Optimization And Innovation Of An Inflammation-related Prognostic Evaluation System For Gastric Cancer And Characteristics And Prognostic Significance Of Profiling The T-cell Receptor Repertoire In Patients With Gastric Cancer
53. The Recent Efficacy Of Different Surgical Approaches For Treating Siewert Ⅱ Adenocarcinoma Of The Esophagogastric Junction
54. The Value Of Predicting Human Epidermal Growth Factor Receptor 2 Status In Adenocarcinoma Of The Esophagogastric Junction In Different Models Of CT-based Radiomics
55. Benefit Of Abdominal Lymph Node Dissection And Prognosis Of No.16 Lymph Node Metastasis In Patients With Resectable Adenocarcinoma Of The Esophagogastric Junction
56. Comparison Of The Effect Of Two Surgical Approachs In The Treatment Of Esophageal-gastric Junction Adenocarcinoma Of Siewert Type Ⅱ
57. Application Of Artificial Intelligence Based On Deep Learning In The Detection Of Early Adenocarcinoma Of The Esophagogastric Junction Under White Light Endoscopy
58. Investigation Of The Surgical Mode Of Proximal Gastrectomy And Total Gastrectomy For Siewert Ⅱ/Ⅲ Type Adenocarcinoma Of The Esophagogastric Junction
59. Meta-analysis Of The Efficacy And Safety Of Neoadjuvant Chemotherapy Followed By Radical Gastrectomy For Esophagogastric Junction Adenocarcinoma
  <<First  <Prev  Next>  Last>>  Jump to